1 report

EnGenelC I/ II ## ## (EGFR)-EDV- D## EnGenelC PR May ##, 2019 - The first four patients have been dosed in a Phase ##/ ##a study using the Company' s tumor-targeting, EGF-R targeted delivery of cytotoxic payload Advanced pancreatic cancer and other EGF

  • Biopharmaceutical
  • Cancer Immunotherapy
  • Immunotherapy
  • Targeted Delivery
  • Targeted Therapy